lobbying_activities: 1655984

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1655984	11b6bc65-4da6-4acf-bf85-3e58633a96cc	Q1	HEALTHCARE INSTITUTE OF NEW JERSEY	75251	HEALTHCARE INSTITUTE OF NEW JERSEY	2015	first_quarter	HCR	Promoting awareness of the biopharmaceutical and medical technology sectors. Opposing the imposition of price controls in the Medicare program. Generally supporting the delay and repeal of the medical device excise tax. Supporting HR 160, the Protect Medical Innovation Act. Supporting S 149, the Medical Device Access and Innovation Protection Act. Supporting HR 2, the Medicare Access and CHIP Reauthorization Act. Generally supporting intellectual property rights. Supporting HR 1078, the FDA Safety over Sequestration Act. Opposing Senate Amendment 921 regarding price controls in Medicare Part D. Generally supporting the House Energy and Commerce Committee's 21st Century Cures initiative	HOUSE OF REPRESENTATIVES,SENATE		86222	0	0	2015-04-03T10:35:26.227000-04:00